CUV vs EYE

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CUV

CLINUVEL FPO [CUV]

61MEDIUM-HIGH

EYE

NOVA EYE FPO [EYE]

57MEDIUM

Score Breakdown

CUV EYE
Technical
47
57
Catalyst
55
53
Sentiment
50
50
Fundamental
71
76
Momentum
56
39
Risk Gate
40
45

Key Metrics

CUV Metric EYE
$513.9MMarket Cap$32.8M
122KAvg Volume (20d)269K
+9.0%Short InterestN/A
$14.00052-Week High$0.205
$8.35052-Week Low$0.100
-1.3%Daily Change+0.0%
$10.090Reference Price$0.115
+14.0%ROE-42.4%
+33.8%Profit Margin-21.3%

Active Signals

CUV Signals

●MACD momentum is losing steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (5.3x)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

EYE Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.0x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare CUV and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CUV vs IIQ →CUV vs LGP →CUV vs PNV →CUV vs PTX →CVB vs EBO →
CUV Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).